^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ewing Sarcoma |
| Drug: | ONCT-216 (ETS inhibitor, EWS-FLI1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Oncternal Receives Fast Track Designation for TK216 in Relapsed or Refractory Ewing Sarcoma
Published date:
06/20/2016
Excerpt:
...TK216 has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with Ewing sarcoma who have relapsed or are refractory to standard of care therapy.
